<div><p> New blood tests are set to change how Alzheimer's is diagnosed and treated by offering an easy way to see if patients have amyloid plaques and tau tangles in their brains — hallmarks of the disease. </p><nbtemplate data-id="AdPlaceholder" data-content="JTdCJTdE"></nbtemplate><p class=fullattribution> Copyright 2024 NPR </p></div>

Columbus, OH

The Hill

A blood test can determine whether memory loss is caused by Alzheimer’s disease with more than 90 percent accuracy, according to a new study published Sunday. A group of researchers at Lund University in Sweden found that a cutting-edge blood test can significantly outperform diagnoses from both primary care and specialist doctors. The study, published…

Blood test has a 90 percent accuracy rate in determining whether memory loss is due to Alzheimer’s: Study

A simple blood test shows promise as a way to detect Alzheimer’s disease, which could drastically improve the accuracy and speed of diagnoses. Currently, Alzheimer’s is diagnosed via a mixture of memory and cognitive tests, as well as brain imaging and lab tests. But those tests are often aimed at ruling out other possible causes of symptoms, according to the National Institute on Aging. Even then, misdiagnosis is rampant; the researchers behind a new study wrote that up to 35% of patients in specialized clinics receive the wrong diagnosis. That number likely rises for patients who only visit a primary care facility.

Blood Test Shows Promise for Alzheimer’s Diagnosis

Summary: A novel study finds that specialized MRI scans can detect early brain changes that indicate a higher risk for Alzheimer’s disease (AD) before significant cognitive decline occurs. Researchers discovered that cortical microstructural changes in the brain closely resemble patterns seen in AD pathology. This early detection method could...

MRI Scan Predicts Alzheimer’s Risk Before Symptoms Appear

ScienceAlert


Human brains are destined to fail. Determining whether memory decline is a sign of more than typical aging requires technology that isn't always available, leaving specialists to rely solely on their experience and judgment to spot signs of dementia.



					
			

However, scientists have now confirmed that an already clinically available blood test can supplement current diagnostic methods where expensive scans and spinal fluid samples aren't options, and it appears to deliver extremely high accuracy as well.
Researchers at Lund University in Sweden led a team of scientists in evaluating whether a combination of protein ratios found in human serum can accurately detect ...

This New Blood Test Identifies Alzheimer's Memory Loss With 90% Accuracy

Scripps News

A new study shows a blood test for Alzheimer's worked better than the current standard. Right now, doctors conduct cognitive tests and brain scans.

Study: Alzheimer's blood test diagnosed 91% of dementia cases

Irish Star

Dementia is a condition that affects cognitive abilities, but memory is not the first thing to go, and there are symptoms that appear before memory loss

Five early dementia symptoms you'll notice before memory loss

The Mirror US

Although there is currently no known cure for Alzheimer's, there are treatments that can lessen its symptoms, including disorientation and memory loss, and some may even stop the disease's progression

New Alzheimer's treatment could reverse brain disease and restore memory, study finds

Dementia primary symptom is memory loss, but there are also other warning signs to look out for in the early stages of the disease, one of which is a change in the way a person walks

Four early signs of dementia that can be detected while walking


A little-known form of dementia, easily mistaken for Alzheimer's disease, now has a brand new name and specific diagnostic criteria.
Researchers are calling it limbic-predominant amnestic neurodegenerative syndrome (LANS), and they hope that their work makes it easier for medical professionals to care for and counsel patients with various forms of memory loss.



					
			

LANS presents with a different set of brain changes to  Alzheimer's, and it tends to progress slower and with milder symptoms, mostly impacting those over the age of 80.
Similar to Alzheimer's, a definitive diagnosis is only available upon autopsy.
To help those living with memory loss, neurologist Nick Corriveau-Lecavalier...

Scientists Name New Type of Memory Loss Often Mistaken For Alzheimer's

Health Digest

The first signs of cognitive decline in an older relative could hint at a condition called dementia. One form, Alzheimer's dementia, manifests in 7 stages.

The 7 Stages Of Dementia Before Death Explained

From blood markers and brain scans to eye tests and voice cues, there are a myriad of ways that researchers are trying to detect dementia long before it sets in – and those studies are all just from the past six months. One common indicator of cognitive decline is...

New Test Could Tell if You Have Early Signs of Dementia With High Accuracy

The US Sun

Scientists have developed a tool to assess just that, and it can help predict if you're at risk of having a stroke, dementia and depression in later life. Dubbed the 'Brain Care Score' (BCS), the test assesses 12 modifiable physical, lifestyle and social-emotional factors. It looks at things like your...

What’s your ‘Brain Care Score’? The 12-question test that ‘could predict your risk of dementia, stroke and depression’

TIME

After a specialist visited the White House, speculation about Joe Biden's health swirled. Here's how Parkinson's is actually diagnosed.

How Is Parkinson’s Disease Diagnosed?

The use of Montelukast oral film, an experimental therapy being repurposed by Intelgenx to treat mild to moderate Alzheimer’s disease, led to significant improvements in patients’ cognition versus a placebo in a Phase 2 clinical trial. That’s according to the findings of a top-line analysis of efficacy data...

Montelukast oral film may help in mild to moderate Alzheimer’s

WEKU

An international group of researchers has voted to modify the scientific names of more than 200 plant species whose names carry a derogatory word.

Some plant names can be racist. Scientists are looking to rename them

In the Pacific Northwest, some tributaries salmon travel through to spawn are so hot that it’s threatening their migration. In some places, biologists have trucked the fish to cooler water.

Salmon are struggling to migrate in hot waters along their route. So they're driving

CBS News

There may be new hope in the fight against dementia, according to recent research that found the latest shingles vaccine appears to delay the onset of the memory-impairing condition.In the study, published in Nature Medicine on Thursday, researchers found people who got the vaccine lived, on average, an additional 164 days without a dementia diagnosis compared to those who received the previous shingles vaccines.On "CBS Mornings" Friday, Dr. Céline Gounder, CBS News medical contributor and editor-at-large for public health at KFF Health News, said the results were exciting. "The fact that we have a vaccine that's already approved, already out there, covered...

Latest shingles vaccination may also help delay dementia, study finds


As the global population ages, more of us face frightening cognitive decline, personally or in our loved ones. There are over 10 million new cases of dementia globally each year.



					
			

But a new study suggests up to 13 percent of people diagnosed with dementia in the US may have a misdiagnosis and are instead left struggling with a condition that can be treated.
"Health care providers [must be] made aware of this potential overlap between dementia and hepatic encephalopathy, which is treatable," states Virginia Commonwealth University hepatologist Jasmohan Bajaj.
Hepatic encephalopathy – cognitive impairment caused by liver failure – impacts more than 40...

Up to 13% of Dementia Cases May Be a Misdiagnosed Treatable Condition

In the U.S., there are about 500 accredited geriatric emergency departments, designed to be less dangerous, less stressful places for older adults to get care.

Older adults are often misdiagnosed. Specialized ERs and trained clinicians can help

The European Medicines Agency (EMA) has denied approval for lecanemab, a drug being currently developed to help against Alzheimer’s. It has been reported that the drug has been showing the ability to start slowing cognitive decline. However, the EMA also concluded that there are indeed some risks and possible severe side effects such as brain bleeding and swelling.

Alzheimer’s Drug Lecanemab Rejected in Europe

New blood tests are set to change how Alzheimer's is diagnosed and treated by offering an easy way to see if patients have amyloid plaques and tau tangles in their brains — hallmarks of the disease.

A new kind of blood test can detect signs of Alzheimer’s with remarkable accuracy

Comments / 0